Abstract
Sulfonation as one of the most important modification reactions in nature is essential for many biological macromolecules to function. Development of green sulfonate group donor regeneration systems to efficiently sulfonate compounds of interest is always attractive. Here, we design and engineer two different sulfonate group donor regeneration systems to boost the biosynthesis of sulfated compounds. First, we assemble three modules to construct a 3'-phosphoadenosine-5'-phosphosulfate (PAPS) regeneration system and demonstrate its applicability for living cells. After discovering adenosine 5’-phosphosulfate (APS) as another active sulfonate group donor, we engineer a more simplified APS regeneration system that couples specific sulfotransferase. Next, we develop a rapid indicating system for characterizing the activity of APS-mediated sulfotransferase to rapidly screen sulfotransferase variants with increased activity towards APS. Eventually, the active sulfonate group equivalent values of the APS regeneration systems towards trehalose and p-coumaric acid reach 3.26 and 4.03, respectively. The present PAPS and APS regeneration systems are environmentally friendly and applicable for scaling up the biomanufacturing of sulfated products.
Similar content being viewed by others
Introduction
Sulfonation reactions that catalyzed by diverse sulfotransferases1,2 transfer a sulfonate group (-SO3H) to a hydroxyl group in compounds and perform one of the most important modification reactions in nature3,4. Sulfonation is essential for bioactivation or detoxification5,6 because it changed the biophysical properties of biomolecules, such as polysaccharides7,8, proteins9,10,11, hormones12, and lipids13. Due to the diversified physiological functions and wide applications14 of these sulfate-containing compounds, the biomanufacturing of these compounds is imperative. Moreover, 3′-phosphoadenosine-5′-phosphosulfate (PAPS) has been accepted as the unique active sulfonate group donor for all biological sulfonation reactions15,16 and adequate supply of PAPS is a prerequisite for accomplishing efficient biosynthesis of these sulfated compounds.
As pioneering research, a rat aryl sulfotransferase IV (AST IV)-dependent PAPS regeneration system was creatively constructed with p-nitrophenyl sulfate (PNPS) as the primary sulfonate donor17. Thereafter, different AST IV enzymes have been investigated to optimize the PAPS regeneration system for rapid determination of sulfotransferase activity and enzymatic synthesis of chondroitin sulfate18,19 and heparin20. In view of the high price of 3′-phosphoadenosine-5′-phosphate (PAP), PAPS was added for one-pot chemoenzymatic synthesis of heparin with the AST IV-dependent PAPS regeneration system21,22,23. However, accumulation of the toxic byproduct p-nitrophenol (PNP) and the comparatively high cost of substrate PNPS restrict their large-scale applications24. Consequently, many studies have recently concentrated on the biosynthesis of PAPS with adenosine 5′-triphosphate (ATP) as substrate25,26,27. To reuse the byproduct adenosine 5′-diphosphate (ADP) and increase the conversation rate, a high-energy compound phosphoenolpyruvate was introduced28. Recently, polyphosphate especially polyP6 has been applied as phosphate donors to drive ATP regeneration for enzymatic biosynthesis of valuable compounds29,30,31 because of its low price. In particular, after creating an artificial bifunctional ATP sulfurylase-APS (adenosine-5′-phosphosulfate) kinase (ASAK) and screening pyrophosphate (PPi) kinase, Xu and colleagues engineered efficient ATP regeneration systems with intrinsic byproduct PPi or supply of polyP6 for equimolar conversion of PAPS from ATP32. Even so, large amounts of PAPS are still required for sufficient sulfonation while the accumulated PAP exhibits feedback inhibition on sulfotransferases33,34. Hence, it is preferable to engineer alternative green sulfonate group donor regeneration systems for biomanufacturing of sulfated products.
In this work, a de novo PAPS regeneration system is designed and constructed by integrating three modules for ATP biosynthesis from AMP, conversion of PAPS from ATP and regeneration of AMP from PAPS, in which specific sulfotransferase is coupled for sulfonating compounds of interest. We also demonstrate its applicability in living cells for biosynthesis of sulfated products. We discover and validate APS, the precursor of PAPS, is also an active sulfonate group donor. An indicating system is constructed for rapidly characterizing and screening sulfotransferase variants with higher activities towards APS. After engineering the PAPS/APS binding site 3′-PB (3′-phosphate-binding motif) region of sulfotransferases, the APS utilization efficiency is significantly improved. Eventually, an APS regeneration system with short route (three enzymes in total) is developed for sulfonation.
Results
Design of an in vitro PAPS regeneration system
Although the AST IV-dependent PAPS regeneration system has been used for enzymatic synthesis of sulfonated compounds18,21,35, more green alternative PAPS regeneration systems are still imperative. Inspired by the studies on the widely distributed PAPS metabolism36 (Fig. 1a), we designed a PAPS regeneration system by assembling three modules: the conversion of ATP from AMP, the biosynthesis of PAPS from ATP and the regeneration of AMP from PAPS, in which the inexpensive substrate sulfate and polyphosphate were used as initial raw materials (Fig. 1b). For Module I, polyphosphate kinases, especially the polyphosphokinase family 2 (PPK2) members that exhibit AMP and ADP phosphorylase activities37 and apply inexpensive polyphosphate (polyP) chains as substrates38 were selected for characterization. As shown in Fig. 1c, liquid chromatogram analysis showed that apart from PPK2p.a-N, all the other polyphosphate kinases exhibited both AMP and ADP phosphorylase activities. In contrast, PPK2s.e (from S. epidermidis) showed the highest enzymatic activity and preferentially utilized AMP (Fig. 1d, Supplementary Fig. 1a). Additionally, the polymerization degree of polyphosphates for supporting AMP and ADP phosphorylases was also investigated, and the results suggested that the degree of polyphosphate polymerization for AMP phosphorylation should be higher than three while for ADP phosphorylation, the minimal polymerization degree was 2 (Supplementary Fig. 1b).
For Module II, the artificial bifunctional PAPS synthase ASAK that constructed in our previous work32 was utilized. Considering the adverse effect of excessive polyphosphate polyP6 on the enzyme activity of ASAK32, the concentration of polyP6 was optimized and determined to be 2.0 mM in the reaction system (Supplementary Fig. 1c). After coupling the sulfonate group transfer reaction, the produced byproduct PAP with a feedback inhibition effect on sulfotransferases was dephosphorylated to generate AMP, which was designed as Module III. Hence, identification of a PAP 3'-phosphatase (CysQ) (EC 3.1.3.7) that specifically hydrolyzes PAP but not PAPS would be of great importance. After expression and purification (Supplementary Fig. 2a), the enzymatic activities toward PAP and PAPS were determined (Supplementary Fig. 2b). The KpCysQ from Komagataella phaffii GS115 that exhibits a high enzymatic activity (81.6 U/mg) (Fig. 1e) was selected and applied for AMP regeneration after confirming its inability towards PAPS (Fig. 1f).
Characterization of the engineered PAPS regeneration system
After optimizing the committed enzymes for Module I and Module III, the sulfonation efficiency of the PAPS regeneration system was compared with that of the acyclic sulfonation systems (Fig. 2a). As examples, chondroitin 4-O-sulfotransferase18 (C4ST) (Fig. 2b) and trehalose sulfotransferase39 (Stf0) (PDB ID: 1TEX) (Fig. 2d, Supplementary Figs. 3 and 4a) were introduced for sulfonating chondroitin and trehalose to generate chondroitin sulfate A (CSA)40 and trehalose-2-sulfate, respectively. After modification, the produced CSA and trehalose-2-sulfate were pretreated and analyzed by liquid chromatography with tandem mass spectrometry (HPLC-MS/MS, Supplementary Fig. 3b, Fig. 4b, c). As shown in Fig. 2c and e, both reactions used to catalyze the transformation of PAP to AMP (Module III) and the regeneration of ATP from AMP (Module I), significantly increased the sulfonation degree and the Active Sulfonate Group Equivalent values (ASGE values, the amount of sulfonate groups transferring to substrate that driven by the initial equal ATP). In comparison, when the complete PAPS regeneration system was applied, the sulfonation degrees of products CSA and trehalose-2-sulfate reached the highest values of 91% and 95%, respectively (Supplementary Figs. 3a and 4d). Correspondingly, the ASGE values of the CSA and trehalose-2-sulfate catalytic systems reached 4.76 and 3.82, respectively.
In parallel, we also compared the current PAPS regeneration system with the commonly used AST IV-dependent recycling system. Obviously, the PAPS regeneration system with polyP6 (energy source) and SO42- (sulfonate donor) produced higher sulfonation degree (Fig. 2f, Supplementary Fig. 5). In general, metal ions for instance Mg2+, Ca2+, and Mn2+ were indispensable for enzymatic reactions. Thus, we further investigated the probable effects of these ions on sulfonation reaction. As shown in Supplementary Fig. 6, no significant influence was detected, suggesting the good compatibility of this PAPS regeneration system. Moreover, the purification of the product trehalose-2-sulfate with anion exchange chromatography (Supplementary Fig. 7) also demonstrated the negligible effects of residual polyphosphate. Furthermore, the ready accessibility of these enzymes (Supplementary Table 1) would also facilitate the scaling up of this PAPS regeneration system.
Re-construction of the PAPS regeneration system for whole-cell transformation
In view of high efficiency of the PAPS regeneration system for sulfonation, it would be also attractive to introduce this regeneration system into living cells. Thus, we firstly investigated the ability of E. coli cells for absorbing polyphosphate substrates such as polyP6 with a fluorescein-depending ATP indicating system (Fig. 3a). Briefly, the firefly luciferase41 (converting luciferin to oxyluciferin) and PPK2s.e (catalyzing AM(D)P to ATP with polyP6 as phosphate donor) encoding genes were introduced into E. coli cells. After cultivation with the addition of 6.0 g/L polyP6, E. coli cells were harvested and incubated with fluorescein, and then the intracellular oxyluciferin intensity that reflecting the concentration of ATP was detected. As shown in Fig. 3b, stronger fluorescence intensity was observed with addition of polyP6 during cultivation. Meanwhile, ATP analysis results also confirmed that addition of polyP6 during cultivation resulted in much higher level of intracellular ATP (Fig. 3c). The results demonstrated the ability of E. coli cells to assimilate extracellular polyP6. Then, all the enzymes of Modules I, II and III were introduced into E. coli cells to re-construct an in vivo PAPS regeneration system (Fig. 3d). In order to enhance the uptake of sulfate (Supplementary Fig. 8), the sulfate transporter gene cluster cysPUWA in the genome was upregulated with the strong T7 promoter. As an example, the sulfotransferase AST IV with broad substrate spectrum42 was overexpressed with N-terminal fusion of GST tag (Supplementary Fig. 9a) in E. coli for whole-cell transformation of zosteric acid (a natural anti-adhesive agent, Supplementary Fig. 9bc) from p-coumaric acid (Fig. 3d). As shown in Fig. 3e, f, it could be found that introduction of the PAPS regeneration system resulted in a 14.3-fold increase for zosteric acid biosynthesis (1.51 g/L). When further enhancing sulfate uptake, the titer of zosteric acid was increased to 1.73 g/L from 2.0 g/L substrate p-coumaric acid, with a conversion rate of 86% (Fig. 3f). The results proved the PAPS regeneration system constructed here could also be applicable for living cells.
APS is also a universal active sulfonate donor
In nature, NADPH and its unphosphorylated counterpart NADH are important cofactors involved in many oxidation-reduction reactions and can be recognized by specific oxidoreductases43,44,45. Similarly, APS is the unphosphorylated form of PAPS (Fig. 4a). Therefore, we speculated that APS might also be an active sulfonate donor for sulfotransferases. To this end, we selected both cytosolic and membrane sulfotransferases (Fig. 4b), including Stf0 (Fig. 4c), heparan sulfate N-sulfotransferase (NST) (Fig. 4d), chondroitin 4-O-sulfotransferase (C4ST) (Fig. 4e), estrogen sulfotransferase (Fig. 4f) and AST IV (Fig. 4g), and studied their activities with APS or PAPS as substrates. Interestingly, HPLC-MS/MS (Supplementary Fig. 10) and kinetic parameter (Table 1) analysis results showed that similar to PAPS, APS can also be recognized and utilized by all the above sulfotransferases. The results countered our long-standing acknowledgment that PAPS is the sole active sulfonate donor in living cells.
Biosynthesis of sulfated compounds with an APS regeneration system
We attempted to construct a short APS generation system for sulfonated modification, in which APS was converted to AMP in one reaction step and only one reproducible ATP was needed as a scaffold (Fig. 5a, Supplementary Fig. 11). Moreover, after transferring the sulfonate group, the product AMP could be directly phosphorylated to ATP by PPK2 in the APS regeneration system. After construction, the ASGE values of Stf0 and C4ST coupling with the APS regeneration system were determined as 2.18 and 2.68, respectively (Supplementary Fig. 12). In view of the broad substrate spectrum17,46, the sulfotransferase AST IV was chosen for sulfonating a series of benzene ring containing compounds (Fig. 5b) with the APS regeneration system, including zosteric acid, sulfated 4-acetamidophenol (Supplementary Fig. 13a), sulfated estrogen (Supplementary Fig. 13b), sulfated dopamine (Supplementary Fig. 14 and sulfated naringenin (Supplementary Figs. 15 and 16), which have been widely used as important drugs and building blocks47,48,49. Overall, the results suggest that the engineered APS regeneration system shows great potential for cell-free and in vivo sulfonation reactions.
Development of an APS-mediated sulfotransferase activity indicating system
Compared with the PAPS regeneration system, the APS regeneration system achieved comparatively lower ASGE values towards sulfotransferases (Fig. 2, Supplementary Fig. 12). Hence, to construct and rapidly characterize sulfotransferase variants with higher activities towards APS, an APS-mediated sulfotransferases activity indicating system was proposed and established. In the APS regeneration system, PPi, AMP, and ATP as intermediate products were produced (Fig. 5a) while it has been reported that pyruvate phosphate dikinase (mmPPDK) from Methanosarcina mazei50 catalyzes the interconversion of AMP, PPi, and phosphoenolpyruvate (PEP) with ATP, Pi and pyruvate (Fig. 6a). As a consequence, we recruited the specific sulfotransferase Stf0, mmPPDK and the lactate dehydrogenase (paLDHA for the conversion of pyruvate and NADH to lactic acid and NAD+) to accomplish the rapid analysis of sulfonation that driven by APS with detection of the absorbance decrease at 340 nm (Fig. 6b). Specifically, all the enzymes were expressed with E. coli cells and purified for next step verifying (Supplementary Fig. 17). After successfully engineering the indicating system, the effects of all the components of the system on the reaction that catalyzed by paLDHA were studied. The results showed that ATP, ADP, AMP, PEP, and PPi generated no obvious negative effects while Mg2+ produced a positive effect (Supplementary Fig. 18). Further examination of the absorbance-drop values at 340 nm and the consistent liquid chromatography-mass spectrometry assay results demonstrated the reliability of this indicating system (Fig. 6c).
Semi-rational engineering of sulfotransferases to enhance APS utilization efficiency
After engineering the above rapid indicating system, we concentrated on uncovering the key residues affecting substrate recognition and enhancing APS utilization efficiency. Accordingly, two conserved 5′PSB and 3′PB motifs that interact with the 5′-phosphosulfate group and 3′-phosphate group of PAPS, respectively, were displayed in the local 3D structure of Stf0 sulfotransferase19,39,51 (PDB: 1TEX) (Fig. 7a; Supplementary Fig. 19). According to previous studies, the residues arginine and serine of the 3′PB motif should help position PAPS in sulfotransferases52,53. Thus, the residues R143, V151, S152, and W154 in Stf0, and R132, V139, S140, and Y141 in AST IV were selected for saturation mutation after further multiple sequence alignment (Fig. 7b). The mutation process was followed as Fig. 7c and the enzyme activity was measured according to the APS-mediated indicating system (Fig. 6b). As shown in Fig. 7d, the single mutations R143C, S152P, and W154N dramatically improved the activity of Stf0 for APS. The variant Stf0R143C/W154N with the highest activity towards APS (comparable to PAPS) was further constructed by combinatorial mutation (Fig. 7f). For AST IV, the positive single mutations are R132N, V139G, S140I, and S140E (Fig. 7e) while the best combinatorial variant is AST IV R132E/S139G/S140I (Fig. 7g). These results suggest that reprogramming of the 3′PB motif of sulfotransferases can improve the activity and affinity (Supplementary Table 2) towards APS. Eventually, the constructed combinatorial variants Stf0R143C/W154N and AST IV R132E/S139G/S140I were used for sulfonating trehalose and p-coumaric acid with the APS regeneration system. Compared with the wild type Stf0 and AST IV (Fig. 5b, Supplementary Fig. 12), Stf0R143C/W154N and AST IV R132E/S139G/S140I with higher affinity to APS generated significantly increased ASGE values, which were 3.26 (85% yield) and 4.03 (89% yield), respectively (Fig. 7h, i). These results demonstrated that sulfonated modification with efficient APS-mediated sulfonate group regeneration systems by rational engineering of sulfotransferases is feasible and convenient for practical applications.
Discussion
Performing enzymatic modification through sulfonation involving the consumption of PAPS and accumulation of the byproduct PAP is always a challenging task. In this study, we designed and constructed a de novo PAPS regeneration system by assembling the following three modules: the biosynthesis of ATP from AMP (Module I), the conversion of PAPS from ATP (Module II) and the regeneration of AMP from PAPS (Module III) (Fig. 1b). As a result, we achieved the enzymatic biosynthesis of sulfated compounds including chondroitin sulfate A (Fig. 2d) and trehalose-2-sulfate (Fig. 2e), by providing inexpensive substrate sulfate (SO42- as sulfonate donor) and polyP6 (as energy source). Compared to the traditional PNPS-dependent system used for PAPS regeneration20, this route is more promising since no high-cost substrates were added and no toxic byproducts such as PNP, accumulated during sulfonation and PAPS regeneration (Fig. 1b). Moreover, compared with the biotransformation system by directly providing PAPS22,54,55, this PAPS regeneration system produced higher sulfonation degree (Fig. 2, Supplementary Fig. 3, Table 3), the reason should be ascribed to the continuous supply of PAPS and the elimination of PAP accumulation. It has been reported that the presence of PAP, especially with a high concentration55, should affect PAPS utilization since the continued occupation of PAP in the sulfotransferase pocket resulted in the prevention of PAPS binding34. In addition, after demonstrating the ability of E. coli cells for absorbing extracellular polyP6 and successfully re-constructing the in vivo PAPS regeneration system (Fig. 3), it could be concluded that this constructed PAPS regeneration system should have broad applications in the fields of multi-enzyme catalysis and metabolic engineering especially for sulfated products56.
Generally, the ATP regeneration system (Module I) requires different classes of polyphosphokinases for cascade phosphorylation of AMP and ADP30. Here, considering the AMP and ADP phosphorylase activities of PPK2 observed57, we comparatively investigated PPK2 from different species and finally selected PPK2s.e to perform the direct biocatalytic synthesis of ATP from AMP (Fig. 1c). The application of PPK2 containing both AMP phosphorylase and ADP phosphorylase improves regeneration efficiency and simplifies ATP regeneration in various scenarios. Furthermore, our results also demonstrated that PPK2s.e exhibits higher affinity toward AMP and preferentially phosphorylates AMP to ATP through ADP (Fig. 1c, d). These results increase our knowledge on the enzymatic properties of PPK2 family enzymes58. In parallel, the identification of KpCysQ from K. phaffii GS115 for selectively breaking down PAP to AMP (Fig. 1e) but not PAPS to APS (Fig. 1f) suggests that CysQ should have an identification mechanism to distinguish PAP and PAPS (Fig. 1f) even though it has been reported that CysQ as part of the larger FIG superfamily of phosphatases exhibits dephosphorylation activities toward different monosaccharide-containing substrates59,60.
To date, studies on sulfur metabolism have mainly concentrated on pathogenic and sulfur bacteria61,62,63. It has always been accepted that PAPS is the sole universal sulfate donor in all biochemical reactions. Here, we demonstrated that in addition to PAPS, APS is also an active sulfate donor and can be recognized by different cytosolic and membrane sulfotransferases (Fig. 4b). This finding provides insights into our understanding of the physiological functions of APS and PAPS. Moreover, from the perspective of application, we simplified the PAPS regeneration system (Fig. 1b) into an APS regeneration system (Fig. 5a), resulting in the continuous conversion of APS from sulfate and polyP6 with one molecule of ATP as the intermediate (Fig. 5a). Moreover, after construction of an APS-mediated sulfotransferase activity indicating system by adopting PPDK50, LDHA and specific sulfotransferase (Fig. 6b), we semi-rationally modified sulfotransferases Stf0 and AST IV and rapidly screened the variants of Stf0R143C/W154N and AST IV R132E/S139G/S140I with higher APS activities (Fig. 7d, e). As a consequence, specific efficient APS regeneration systems were developed for sulfonating trehalose (Fig. 7h) and p-coumaric acid (Fig. 7i), respectively. The results suggest that with the help of the APS-mediated sulfotransferase activity indicating system, it would be convenient and effective to engineer sulfotransferases for developing APS regeneration systems with high capacity.
Overall, a PAPS regeneration system from sulfate and polyphosphate was designed and successfully constructed in this study by assembling three modules. After demonstrating the ability of E. coli cells for absorbing polyP6, the PAPS regeneration system was introduced into living cells for whole-cell transformation. Then, after identifying APS as another active sulfonate group donor, a more simplified APS regeneration system was further engineered for sulfonated modification. In particular, an APS-mediated sulfotransferase activity indicating system was established for rapidly screening sulfotransferase variants with satisfactory activity and affinity to APS. The alternative PAPS and APS regeneration systems for sulfonated modification were environment-friendly and applicable to be scaled-up for boosting the biomanufacturing of various sulfated natural products.
Methods
Bacterial strains and reagents
Escherichia coli strain JM109 was used for all cloning experiments, and E. coli strain BL21(DE3) was used for protein expression. Adenosine 3′-phosphoadenosine 5′-phosphosulfate triethylammonium salt (>90%), adenosine 5′-phosphosulfate sodium salt (>85%), sodium pyrophosphate (>99%), and sodium hexametaphosphate (>96%) were purchased from Sigma-Aldrich (Shanghai, China). Common reagents were purchased from Sinopharm (Beijing, China).
Genetic construction
All the primers designated and plasmids constructed in this work are listed in Supplementary Data 1, 2, and 3. Artificial bifunctional PAPS synthase (ASAK) contains ATP sulfurylase from Saccharomyces cerevisiae and APS kinase from E. coli K1232. The polyP kinases genes ppk2Apa (Gene ID: 879494), ppk2Bpa (Gene ID: 882843), ppk2Cpa (Gene ID: 878853, ppk2CpaN (ppk2Cpa(a1‑g753)), ppk2CpaC, ppk2Cpa(c748‑g1491)), ppk2rp (UniProtKB: Q5LX16, Ruegeria pomeroyi), ppk2se (UniProtKB: A0A6N3RU13, S. epidermidis), and ppk2dr (UniProtKB: M9XB82, Meiothermus ruber) were amplified or synthesized and inserted into the pET28a(+) plasmid32. Codon-optimized genes of trehalose sulfotransferase (Stf0, Sequence ID: AWT51695.1), estrogen sulfotransferase (EST, Sequence ID: P49891.2), firefly luciferase (luciferase, GenBank: BAM38523.1) and pyruvate phosphate dikinase (mmPPDK, Sequence ID: 44088594) were synthesized by Sangon Biotech (Shanghai, China) and inserted into the pET28a (+) plasmid. 3′(2′),5′-bisphosphate nucleotidase cgCysQ (GeneID: 58311165, Corynebacterium glutamicum, https://www.ncbi.nlm.nih.gov/protein/WP_003858358.1/), ecCysQ (E. coli str. K-12 substr. MG1655, GeneID: 948728), paCysQ (P. aeruginosa PAO1, GeneID: 881784), scCysQ (S. cerevisiae S288C, GeneID: 854090), kpCysQ (GeneID: 8198929, K. phaffii GS115), and paLDHA (GeneID: 881895, P. aeruginosa PAO1) were amplified and inserted into the pET28a (+) plasmid using the T5 exonuclease DNA assembly (TDEA) method64.
Genomic promoter replacement
Genome integration and promoter replacement was performed using the CRISPR-Cpf1 gene editing system, and the editing process was mediated by the pEcCpf1/pcrEG double-plasmid system65. Two homologous sequences of the template were amplified from the genome of E. coli BL21(DE3) using the primer pairs CysP3-F/CysP3-R and CysP4-F/CysP4-R. Primer pairs CysP1-F/CysP1-R, CysP2-F/CysP2-R were used for the construction of the sgRNA expression cassette using the plasmid pcrEG as a template. All four fragments were assembled to generate the plasmid pcrEG-CysPUWA using the TDEA method.
Protein expression and purification
After an overnight incubation in LB medium at 37 °C, recombinant E. coli strains were transferred to TB medium and cultivated for 8−12 h at 30 °C, and 220 rpm, and 0.5 mmol/L isopropyl-β-D-thiogalactopyranoside was added to induce target protein expression. Cells were collected by centrifugation (5000 × g, 4 °C, 15 min) and disrupted by sonication (50 mM Tris-HCl buffer pH 7.5, ice bath). The supernatant was obtained by centrifugation (10,000 × g, 4 °C, 30 min).
Proteins were purified from the supernatant of the cell lysates by nickel-affinity chromatography with AKTA start 25 (GE Healthcare, USA) with washing buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl) and elution buffer (50 mM Tris-HCl, pH 7.5, 500 mM imidazole, 150 mM NaCl). The purified protein solutions were desalted using a HiTrap desalting column (GE Healthcare, USA) with washing buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl). Protein concentration was determined using a Bradford protein assay kit from Beyotime (Shanghai, China) using bovine serum albumin as the standard. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) analysis was performed using 10–12% bis-tris protein gels (NuPAGE, Thermo Scientific), and the gels were stained with Coomassie Brilliant Blue solutions.
Activity assay of the polyP kinases
The phosphorylation reaction was carried out in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, buffer, containing 10 mM ADP (or 10 mM AMP or both 5 mM ADP and 5 mM AMP), 5.0 g/L polyP6 (polyP3, or PPi), 20 mM MgSO4, and 0.5 g/L purified polyP kinases. After the mixture was incubated at 35 °C for a designated time (0–60 min), the reaction was terminated by adding an equal volume of methanol. One unit of activity was defined as the amount of enzyme needed to catalyze the formation of 1 μmol ATP (or 1 μmol ADP) at 35 °C within 1 min. Specific activity was expressed in unit/mg protein.
Quantification of AMP, ADP, ATP, PAP, PAPS, and APS
High performance liquid chromatography equipped with an Agilent 1260 system was used for quantification of AMP, ADP, ATP, PAP, PAPS and APS. A YMC-Pack Polyamine II column was used for quantification of PAP, PAPS and APS. HPLC was performed as follows: the composition of the mobile phase was 50 mM KH2PO4 with 0.1% (v/v) triethylamine and 10% acetonitrile. The injected volume of all samples was 5 μL, and the column temperature was set to 30 °C with a flow rate of 0.6 mL/min. Fractions were detected by UV absorbance at a wavelength of 254 nm.
A Hypersil GOLD™ aQ (250 × 4.6 mm, 5 μm, Thermo Scientific™) was used for quantification of AMP, ADP, and ATP. The HPLC detection conditions were as follows: the composition of the mobile phase was 50 mM KH2PO4-K2HPO4, pH 6.7. The injected volume of all samples was 5 μL, and the column temperature was set to 30 °C with a flow rate of 0.8 mL/min.
Activity assay of sulfotransferases
A reaction mixture containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5-10 mM PAPS (5–10 mM APS), 10 mM MgSO4, 0.5 mg/mL sulfotransferases and 10 mM (polymers for 5 g/L) nonsulfonated substrate was prepared in a total volume of 1000 μL. The reaction mixture was incubated at 35 °C for 6 h and quenched by adding 1000 μL of methanol. The resultant mixtures were centrifuged at 10,000 × g for 10 min. One unit of activity was defined as the amount of enzyme needed to catalyze the formation of 1 mM sulfated products at 35 °C within one hour. The activities of Stf0 sulfotransferase mutants generated in the first-round screening were measured using APS and trehalose as substrates. Crude enzyme was obtained by lysis of five OD bacteria in Tris-HCl buffer.
Sulfonated products quantification
Sulfonated products were quantified by high performance liquid chromatography-mass spectrometry (Shimadzu LCMS-IT-TOF). Samples were analyzed by an XSelect CSH C18 column, 130 Å, 1.7 µm, 2.1 × 50 mm. The LC conditions were as follows: eluent A (0.1 mol/L ammonium formate) and eluent B (acetonitrile) were used at a flow rate of 0.6 mL/min. MS analyses were simultaneously performed using electrospray ionization in the positive ionization mode (detector voltage 30 V, capillary voltage 3.0 kV, and source block temperature 100 °C) to obtain spectra across a scan range of 20−2000 m/z. To quantify the sulfated products, we isolated the mass spectrum corresponding to the m/z values of the designated products from the parent ion fragments. Subsequently, the concentrations of sulfated products were calculated based on the area of the selected peak. Data were acquired using MassLynx software (version 4.1, ScN870; Waters).
Preparation of PAPS regeneration and APS regeneration system
The PAPS regeneration system was prepared with a mixture containing 50 mM Tris-HCl buffer (pH 7.0), 10 mM ATP, 10 mM MgSO4, 0–50 mM Na2SO4, 0–5 mM polyP6, 0.5 mg/mL ASAK, 0.5 mg/mL KpCysQ and 0.5 mg/mL PPK2s.e. Sulfotransferases and precursors were subsequently combined. The APS regeneration system was mixed with 50 mM Tris-HCl buffer (pH 7.0), 10 mM ATP, 10 mM MgSO4, 0–50 mM Na2SO4, 0–5 mM polyP6, 0.5 mg/mL ATP sulfurylase from S. cerevisiae (ATPSs) and 0.5 mg/mL PPK2s.e.
Intracellular ATP analysis
Cell samples were collected and washed with sterile saline solution. Fluorescein (5.0 g/L) was added to an equal cell density suspension and then incubated for 10 min at 30 °C. To analyze the cell morphology, an Eclipse Ni-E microscope (Nikon, Tokyo, Japan) was used to observe the cell shape and fluorescence under the phase-contrast lens. To analyze intracellular ATP content, the cells were broken and determined using an ATP content assay kit purchased from Sangon Biotech (Shanghai, China)32.
Activity assay of paLDHA and mmPPDK
To assay paLDHA activity, a reaction mixture containing 50 mM Tris-HCl, pH 7.5, 4.0 g/L NADH, 5 g/L pyruvate, and 0.5 mg/mL paLDHA was measured by an Infinite 200 PRO plate reader at an absorbance of 340 nm. One unit of activity was defined as the amount of enzyme needed to oxidize 1 μmol NADH at 30 °C within 1 s. To assay mmPPDK activity, a reaction mixture containing 50 mM Tris-HCl, pH 7.5, 10 mM PEP, 10 mM AMP, 10 mM PPi, and 0.5 mg/mL mmPPDK was prepared in a total volume of 1000 μL. The reaction mixture was incubated at 35 °C for 0–12 h, and then the production of pyruvate was measured. Pyruvate content was measured by a reaction catalyzed by paLDHA, which caused a decrease in absorbance at 340 nm using NADH as the other substrate. One unit of activity was defined as the amount of enzyme needed to catalyze the formation of 1 μmol pyruvate at 35 °C within 1 h. Specific activity was expressed in unit/mg protein.
Phylogenetic analysis of sulfotransferases
Sequence alignment was performed using ESPript66. A phylogenetic tree of sulfotransferases was constructed with the maximum likelihood method using MEGA-X67.
Molecular docking
Molecular docking of Mycobacterium smegmatis Stf0 sulfotransferase (PDB ID: 1TEX) with PAPS and APS was performed using Discovery Studio 4.0. The structure of Stf0 for molecular docking was prepared by eliminating all bound water molecules, and adding hydrogen atoms, which was optimized by applying the CHARMM force field. Amino acids in or near the active pocket were selected to create protein conformations and refine side chains68.
Mutagenesis
Variants were generated using a whole-plasmid mutagenesis protocol. Saturation mutagenesis was then performed on beneficial sites using the NNK codon69. The final mutants were confirmed by DNA sequencing (Sangon Biotech). To assay mutants’ activity, a reaction mixture containing 50 mM Tris-HCl, pH 7.5, 20 mM PEP, 10 mM AMP, 10 mM PPi, 0.5 mg/mL PPDK, 0.5 mg/mL sulfotransferases, 0.5 mg/mL ATPSS, and 10 mM nonsulfonated substrate was prepared in a total volume of 1000 μL. The reaction mixture was incubated at 35 °C for 0-12 h, and then the production of pyruvate by a reaction with changes in absorbance catalyzed by paLDHA was measured.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
Data supporting the findings of this work are available within the paper and its Supplementary Information files. A reporting summary for this Article is available as a Supplementary Information file. Source data are provided with this paper, which are also available at figshare [https://doi.org/10.6084/m9.figshare.24449563]70. Source data are provided with this paper.
References
Blanchard, R. L., Freimuth, R. R., Buck, J., Weinshilboum, R. M. & Coughtrie, M. W. H. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 14, 199–211 (2004).
Men, P. et al. Biosynthesis mechanism, genome mining and artificial construction of echinocandin O-sulfonation. Metab. Eng. 74, 160–167 (2022).
Zhang, Z. et al. Mechanistic and structural insights into the specificity and biological functions of bacterial sulfoglycosidases. ACS Catal. 13, 824–836 (2023).
Luis, A. S. et al. Sulfated glycan recognition by carbohydrate sulfatases of the human gut microbiota. Nat. Chem. Biol. 18, 841–849 (2022).
Malojcić, G. et al. A structural and biochemical basis for PAPS-independent sulfuryl transfer by aryl sulfotransferase from uropathogenic Escherichia coli. Proc. Natl Acad. Sci. USA 105, 19217–19222 (2008).
Liu, F., Yang, H., Wang, L. & Yu, B. Biosynthesis of the high-value plant secondary product benzyl isothiocyanate via functional expression of multiple heterologous enzymes in Escherichia coli. ACS Synth. Biol. 5, 1557–1565 (2016).
Muthukumar, J., Chidambaram, R. & Sukumaran, S. Sulfated polysaccharides and its commercial applications in food industries—A review. J. Food Sci. Technol. 58, 2453–2466 (2021).
Huang, L., Shen, M., Morris, G. A. & Xie, J. Sulfated polysaccharides: Immunomodulation and signaling mechanisms. Trends Food Sci. Technol. 92, 1–11 (2019).
Chen, Y. et al. Unleashing the potential of noncanonical amino acid biosynthesis to create cells with precision tyrosine sulfation. Nat. Commun. 13, 5434 (2022).
Yang, Y. S. et al. Tyrosine sulfation as a protein post-translational modification. Molecules 20, 2138–2164 (2015).
Thompson, R. E. et al. Tyrosine sulfation modulates activity of tick-derived thrombin inhibitors. Nat. Chem. 9, 909–917 (2017).
Mauvais-Jarvis, F., Clegg, D. J. & Hevener, A. L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev. 34, 309–338 (2013).
Radka, C. D., Miller, D. J., Frank, M. W. & Rock, C. O. Biochemical characterization of the first step in sulfonolipid biosynthesis in Alistipes finegoldii. J. Biol. Chem. 298, 102195 (2022).
Bojarová, P. & Williams, S. J. Sulfotransferases, sulfatases and formylglycine-generating enzymes: a sulfation fascination. Curr. Opin. Chem. Eng. 12, 573–581 (2008).
Klaassen, C. D. & Boles, J. W. Sulfation and sulfotransferases 5: the importance of 3’-phosphoadenosine 5’-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 11, 404–418 (1997).
van den Boom, J., Heider, D., Martin, S. R., Pastore, A. & Mueller, J. W. 3′-Phosphoadenosine 5′-phosphosulfate (PAPS) synthases, naturally fragile enzymes specifically stabilized by nucleotide binding. J. Biol. Chem. 287, 17645–17655 (2012).
Burkart, M. D., Izumi, M. & Wong, C. H. Enzymatic regeneration of 3’-phosphoadenosine-5’-phosphosulfate using aryl sulfotransferase for the preparative enzymatic synthesis of sulfated carbohydrates. Angew. Chem. Int. Ed. 38, 2747–2750 (1999).
Zhou, Z. et al. A microbial-enzymatic strategy for producing chondroitin sulfate glycosaminoglycans. Biotechnol. Bioeng. 115, 1561–1570 (2018).
Zhou, Z. et al. Secretory expression of the rat aryl sulfotransferases IV with improved catalytic efficiency by molecular engineering. 3 Biotechnol. 9, 246 (2019).
Datta, P. et al. Expression of enzymes for 3’-phosphoadenosine-5’-phosphosulfate (PAPS) biosynthesis and their preparation for PAPS synthesis and regeneration. Appl. Microbiol. Biotechnol. 104, 7067–7078 (2020).
Zhang, Y. et al. Synthesis of bioengineered heparin by recombinant yeast Pichia pastoris. Green. Chem. 24, 3180–3192 (2022).
Bhaskar, U. et al. Combinatorial one-pot chemoenzymatic synthesis of heparin. Carbohydr. Polym. 122, 399–407 (2015).
Xi, X. et al. Improvement of the stability and catalytic efficiency of heparan sulfate N-sulfotransferase for preparing N-sulfated heparosan. J. Ind. Microbiol. Biotechnol. 50, kuad012 (2023).
Kang, Z. et al. Bio-based strategies for producing glycosaminoglycans and their oligosaccharides. Trends Biotechnol. 36, 806–818 (2018).
DeAngelis, P. L., Liu, J. & Linhardt, R. J. Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature’s longest or most complex carbohydrate chains. Glycobiology 23, 764–777 (2013).
Zhou, X., Chandarajoti, K., Pham, T. Q., Liu, R. & Liu, J. Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3’-phosphoadenosine-5’-phosphosulfate. Glycobiology 21, 771–780 (2011).
Bao, F. et al. Hydrolysis of by-product adenosine diphosphate from 3’-phosphoadenosine-5’-phosphosulfate preparation using Nudix hydrolase NudJ. Appl. Microbiol. Biotechnol. 99, 10771–10778 (2015).
An, C., Zhao, L., Wei, Z. & Zhou, X. Chemoenzymatic synthesis of 3’-phosphoadenosine-5’-phosphosulfate coupling with an ATP regeneration system. Appl. Microbiol. Biotechnol. 101, 7535–7544 (2017).
Cai, T. et al. Cell-free chemoenzymatic starch synthesis from carbon dioxide. Science 373, 1523–1527 (2021).
Petchey, M. R., Rowlinson, B., Lloyd, R. C., Fairlamb, I. J. S. & Grogan, G. Biocatalytic synthesis of moclobemide using the amide bond synthetase McbA coupled with an ATP recycling system. ACS Catal. 10, 4659–4663 (2020).
Gottschalk, J., Blaschke, L., Aßmann, M., Kuballa, J. & Elling, L. Integration of a nucleoside triphosphate regeneration system in the one-pot synthesis of UDP-sugars and hyaluronic acid. ChemSusChem 13, 3074–3083 (2021).
Xu, R. et al. Closed-loop system driven by ADP phosphorylation from pyrophosphate affords equimolar transformation of ATP to 3′-phosphoadenosine-5′-phosphosulfate. ACS Catal. 11, 10405–10415 (2021).
Hatzios, S. K. et al. The Mycobacterium tuberculosis CysQ phosphatase modulates the biosynthesis of sulfated glycolipids and bacterial growth. Bioorg. Med. Chem. Lett. 21, 4956–4959 (2011).
Chapman, E., Best, M. D., Hanson, S. R. & Wong, C. H. Sulfotransferases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew. Chem. Int. Ed. 43, 3526–3548 (2004).
Jin, X. et al. Optimizing the sulfation-modification system for scale preparation of chondroitin sulfate A. Carbohydr. Polym. 246, 116570 (2020).
Günal, S., Hardman, R., Kopriva, S. & Mueller, J. W. Sulfation pathways from red to green. J. Biol. Chem. 294, 12293–12312 (2019).
Motomura, K. et al. A new subfamily of polyphosphate kinase 2 (class III PPK2) catalyzes both nucleoside monophosphate phosphorylation and nucleoside diphosphate phosphorylation. Appl. Environ. Microbiol. 80, 2602–2608 (2014).
Ishige, K., Zhang, H. & Kornberg, A. Polyphosphate kinase (PPK2), a potent, polyphosphate-driven generator of GTP. Proc. Natl Acad. Sci. USA 99, 16684–16688 (2002).
Mougous, J. D. et al. Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis. Nat. Struct. Mol. Biol. 11, 721–729 (2004).
Zhang, W. et al. Enzymatic production of chondroitin oligosaccharides and its sulfate derivatives. Front Bioeng. Biotechnol. 10, 951740 (2022).
Morciano, G. et al. Use of luciferase probes to measure ATP in living cells and animals. Nat. Protoc. 12, 1542–1562 (2017).
Duffel, M. W., Marshal, A. D., McPhie, P., Sharma, V. & Jakoby, W. B. Enzymatic aspects of the phenol (aryl) sulfotransferases. Drug Metab. Rev. 33, 369–395 (2001).
Li, F. L., Zhou, Q., Wei, W., Gao, J. & Zhang, Y. W. Switching the substrate specificity from NADH to NADPH by a single mutation of NADH oxidase from Lactobacillus rhamnosus. Int. J. Biol. Macromol. 135, 328–336 (2019).
Nakamura, M., Bhatnagar, A. & Sadoshima, J. Overview of pyridine nucleotides review series. Circ. Res. 111, 604–610 (2012).
Hallé, F., Fin, A., Rovira, A. R. & Tor, Y. Emissive synthetic cofactors: enzymatic interconversions of tzA analogues of ATP, NAD+, NADH, NADP+, and NADPH. Angew. Chem. Int. Ed. Engl. 57, 1087–1090 (2018).
Rath, V. L., Verdugo, D. & Hemmerich, S. Sulfotransferase structural biology and inhibitor discovery. Drug Discov. Today 9, 1003–1011 (2004).
Huq, A. H. et al. Dopamine 4-sulfate: effects on isolated perfused rat heart and role of atria. Life Sci. 43, 1599–1606 (1988).
Chen, B. et al. Sulfation modification of dopamine in brain regulates aggregative behavior of animals. Natl Sci. Rev. 9, nwab163 (2022).
Everett, J.R. Applications of metabolic phenotyping in pharmaceutical research and development, The Handbook of Metabolic Phenotyping. (eds. J. C. Lindon, J. K. Nicholson & E. Holmes) 407–447 (Elsevier, 2019).
Ye, D. et al. Investigation of the catalytic site within the ATP-grasp domain of Clostridium symbiosum pyruvate phosphate dikinase. J. Biol. Chem. 276, 37630–37639 (2001).
Barbosa, A. C. S., Feng, Y., Yu, C., Huang, M. & Xie, W. Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases. Expert. Opin. Drug. Metab. Toxicol. 15, 329–339 (2019).
Kakuta, Y., Pedersen, L. G., Pedersen, L. C. & Negishi, M. Conserved structural motifs in the sulfotransferase family. Trends Biochem. Sci. 23, 129–130 (1998).
Xie, L. et al. Combinatorial biosynthesis of sulfated benzenediol lactones with a phenolic sulfotransferase from Fusarium graminearum PH-1. mSphere 5, e00949–00920 (2020).
Burkart, M. D., Izumi, M., Chapman, E., Lin, C. H. & Wong, C. H. Regeneration of PAPS for the enzymatic synthesis of sulfated oligosaccharides. J. Org. Chem. 65, 5565–5574 (2000).
Xu, Y. et al. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 334, 498–501 (2011).
Badri, A., Williams, A., Xia, K., Linhardt, R. J. & Koffas, M. A. G. Increased 3’-phosphoadenosine-5’-phosphosulfate levels in engineered Escherichia coli cell lysate facilitate the in vitro synthesis of chondroitin sulfate A. Biotechnol. J. 14, e1800436 (2019).
Parnell, A. E. et al. Substrate recognition and mechanism revealed by ligand-bound polyphosphate kinase 2 structures. Proc. Natl Acad. Sci. USA 115, 3350–3355 (2018).
Nocek, B. P. et al. Structural insights into substrate selectivity and activity of bacterialpolyphosphate kinases. ACS Catal. 8, 10746–10760 (2018).
Erickson, A. I., Sarsam, R. D. & Fisher, A. J. Crystal structures of Mycobacterium tuberculosis CysQ, with substrate and products bound. Biochemistry 54, 6830–6841 (2015).
Neuwald, A. F. et al. cysQ, a gene needed for cysteine synthesis in Escherichia coli K-12 only during aerobic growth. J. Bacteriol. 174, 415–425 (1992).
Bounaga, A. et al. Microbial transformations by sulfur bacteria can recover value from phosphogypsum: a global problem and a possible solution. Biotechnol. Adv. 57, 107949 (2022).
Hatzios, S. K. & Bertozzi, C. R. The regulation of sulfur metabolism in Mycobacterium tuberculosis. PLoS Pathog. 7, e1002036 (2011).
Paritala, H. & Carroll, K. S. New targets and inhibitors of mycobacterial sulfur metabolism. Infect. Disord. Drug Targets 13, 85–115 (2013).
Xia, Y. et al. T5 exonuclease-dependent assembly offers a low-cost method for efficient cloning and site-directed mutagenesis. Nucleic Acids Res. 47, e15 (2019).
Zhu, X. et al. Combining CRISPR–Cpf1 and recombineering facilitates fast and efficient genome editing in Escherichia coli. ACS Synth. Biol. 11, 1897–1907 (2022).
Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320–W324 (2014).
Kumar, S., Stecher, G., Li, M., Knyaz, C. & Tamura, K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 35, 1547–1549 (2018).
Huang, H. et al. Structure and cleavage pattern of a hyaluronate 3-glycanohydrolase in the glycoside hydrolase 79 family. Carbohydr. Polym. 277, 118838 (2022).
Qu, G., Li, A., Acevedo-Rocha, C. G., Sun, Z. & Reetz, M. T. The crucial role of methodology development in directed evolution of selective enzymes. Angew. Chem. Int. Ed. 59, 13204–13231 (2020).
Xu, R. et al. Engineering sulfonate group donor regeneration systems to boost biosynthesis of sulfated compounds. Figshare. https://doi.org/10.6084/m9.figshare.24449563 (2023).
Acknowledgements
This work was financially supported by the National Natural Science Foundation of China (32370066), the National Key Research and Development Program of China (2021YFC2100800), National First-class Discipline Program of Light Industry Technology and Engineering (QGJC20230202), and the Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX23_2487).
Author information
Authors and Affiliations
Contributions
Z.K. and R.X. designed the experiments. R.X. performed the experiments. R.X. and Z.K. analyzed the results. R.X. and Z.K. prepared and revised the manuscript. J.C. performed experiments for E. coli genome integration. W.Z., X.X., Y.W., G.D., J.L. and J.C. participated in revising the manuscript. Z.K. conceived and directed the project. All authors have given approval to the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks Hiroshi Kitagawa, Akio Kuroda, Han Xiao, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xu, R., Zhang, W., Xi, X. et al. Engineering sulfonate group donor regeneration systems to boost biosynthesis of sulfated compounds. Nat Commun 14, 7297 (2023). https://doi.org/10.1038/s41467-023-43195-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-023-43195-1
This article is cited by
-
Construction of immobilized enzyme cascades for the biosynthesis of nucleotide sugars UDP-N-acetylglucosamine and UDP-glucuronic acid
Systems Microbiology and Biomanufacturing (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.